SENISCA is a spinout company from the University of Exeter, founded in 2020 to develop new approaches to reverse cellular senescence (ageing) and treat diseases and aesthetic aspects of ageing.
SENISCA says it has discovered a new and druggable means to reverse senescence through modulation of RNA splicing. The company’s founders have demonstrated that restoration of splicing factor levels to those seen in younger cells is able to effectively turn back the ageing clock in old cells, bringing about reversal of senescence.
A major cause of age-related diseases and the aesthetic signs of ageing is the accumulation of senescent cells in aged tissues and organs; removal of such cells has been shown to be capable of bringing about ‘rejuvenation’ of function in people and animals.
SENISCA plans to develop treatments for age-related chronic diseases using oligonucleotide-based therapeutic approaches to reset splicing factor levels. The company also plans to develop anti-ageing cosmeceuticals.
Subscribe for alerts on new companies featured on Startups.Bio
Archon Biosciences is a biotech company pioneering computationally designed 'Antibody Cages' to unlock powerful therapeutic targets beyond the reach of existing modalities. Archon directly applies …
Founded in 2023, Cytospire Therapeutics is developing a portfolio of next-generation immune cell engagers for treating cancer. The company's multispecific antibodies are designed to harness …
The biotechnology sector is advancing rapidly, fueled by significant venture capital investments that are enabling companies to achieve major breakthroughs. To stay informed about the …
Founded in 2024, Analona Therapeutics is a biotech company located in Denmark focused on developing innovative antibody-based therapies for pancreatic cancer. The company is built …
